Novartis to Pay $422.5 Million Settlement Charges Range from “Off-Label” Marketing to Kickbacks
Wall Street Journal MarketWatch
September 30, 2010
News about the $422.5 million settlement with Novartis made national headlines. “‘As long as they had a prescription pad and were willing to prescribe our products, they qualified as Novartis speakers,’ Jeremy Garrity, a former Novartis employee, said in a statement from his law firm, Nolan Auerbach ‘The company’s illegal business practices were snowballing and nobody was stepping up to stop them. I had to do something.’”